Churg-Strauss syndrome epidemiology and demographics

Jump to navigation Jump to search

Churg-Strauss syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Churg-Strauss syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Churg-Strauss syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Churg-Strauss syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Churg-Strauss syndrome epidemiology and demographics

CDC on Churg-Strauss syndrome epidemiology and demographics

Churg-Strauss syndrome epidemiology and demographics in the news

Blogs on Churg-Strauss syndrome epidemiology and demographics

Directions to Hospitals Treating Churg-Strauss syndrome

Risk calculators and risk factors for Churg-Strauss syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]

Overview

The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year, with higher prevalences seen in Europeans.[1]

Epidemiology and Demographics

Prevalence

The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year.[1][2]

Incidence

The incidence of Eosinophilic granulomatosis with polyangiitis range from 0.5 to 6.8 per million persons per year.[3]

Demographics

Age

The mean age at diagnosis of eosinophilic granulomatosis with polyangiitis is around 45-50 years.

Gender

In general, there is no gender predilection to Eosinophilic granulomatosis with polyangiitis in western nations. In Japan, female predominance has been noted.[4]

Race

In general, there is no racial predilictio to eosinophilic granulomatosis with polyangiitis.

References

  1. 1.0 1.1 Mahr A, Guillevin L, Poissonnet M, Aymé S (2004). "Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate". Arthritis Rheum. 51 (1): 92–9. doi:10.1002/art.20077. PMID 14872461.
  2. Gioffredi A, Maritati F, Oliva E, Buzio C (2014). "Eosinophilic granulomatosis with polyangiitis: an overview". Front Immunol. 5 ( ): 549. doi:10.3389/fimmu.2014.00549. PMC 4217511. PMID 25404930.
  3. Gioffredi A, Maritati F, Oliva E, Buzio C (2014). "Eosinophilic granulomatosis with polyangiitis: an overview". Front Immunol. 5 ( ): 549. doi:10.3389/fimmu.2014.00549. PMC 4217511. PMID 25404930.
  4. Sada KE, Amano K, Uehara R, Yamamura M, Arimura Y, Nakamura Y, Makino H (July 2014). "A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan". Mod Rheumatol. 24 (4): 640–4. doi:10.3109/14397595.2013.857582. PMID 24289197.

Template:WH Template:WS